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Introduction: The growing impact of non-communicable diseases in low- to middle-income
countries makes epilepsy a key research priority. We evaluated peer-reviewed published literature
on childhood epilepsy speciﬁc to Kenya to identify knowledge gaps and inform future priorities.
Methodology: A literature search utilizing the terms “epilepsy” OR “seizure” as exploded
subject headings AND “Kenya” was conducted. Relevant databases were searched, generat-
ing 908 articles. After initial screening to remove duplications, irrelevant articles, and
publications older than 15 years, 154 papers remained for full-article review, which identiﬁed
35 publications containing relevant information. Data were extracted from these reports on
epidemiology, etiology, clinical features, management, and outcomes.
Results: The estimated prevalence of lifetime epilepsy in children was 21–41 per 1,000, while
the incidence of active convulsive epilepsy was 39–187 cases per 100,000 children per year. The
incidence of acute seizures was 312–879 per 100,000 children per year and neonatal seizures
3,950 per 100,000 live births per year. Common risk factors for both epilepsy and acute seizures
included adverse perinatal events, meningitis, malaria, febrile seizures, and family history of
epilepsy. Electroencephalography abnormalities were documented in 20%–41% and neurocog-
nitive comorbidities in more than half. Mortality in children admitted with acute seizures was
3%–6%, and neurological sequelae were identiﬁed in 31% following convulsive status epilepti-
cus. Only 7%–29% children with epilepsy were on antiseizure medication.
Conclusion: Active convulsive epilepsy is a common condition among Kenyan children,
remains largely untreated, and leads to extremely poor outcomes. The high proportion of
epilepsy attributable to preventable causes, in particular neonatal morbidity, contributes
signiﬁcantly to the lifetime burden of the condition. This review reafﬁrms the ongoing
need for better public awareness of epilepsy as a treatable disease and for national-level
action that targets both prevention and management.
Keywords: epilepsy, children, Kenya, epidemiology, management, outcomes
Introduction
Epilepsy is the most common neurological disorder worldwide, contributing to 1%
of the global disease burden.1,2 Low- and middle-income countries (LMICs),
especially sub-Saharan Africa,1,2 bear the highest burden of epilepsy, with children3
being the most affected age-group. The median prevalence of active epilepsy in
high-income countries (HICs) was found to be at 4.9 per 1,000 compared to 12.7
per 1,000 in rural areas of resource-limited countries.3–7 The high burden of
epilepsy is attributed both to high case load associated with increased prevalence
of risk factors. such as preventable brain injuries, and to poor access to health-care
services due to multiple barriers, including ﬁnancial cost. The chronic nature of
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epilepsy has wide-ranging socioeconomic impacts, includ-
ing high health-resource utilization, reduced participation
in education and work due to seizures, comorbidities, and
stigma,behavioral problems, and psychological morbidity,
all of which may contribute to overall poorer quality of
life,1,8–10 in addition to increased mortality rates.1
Insufﬁcient epilepsy diagnosis and a large treatment gap
coupled with lack of appropriate infrastructure in hospitals in
Kenyamakes it challenging to understand the prevalence and
factors associated with this disease in the country.1–8 This
report presents ﬁndings from a review describing the current
literature on epidemiology, diagnosis, management, and out-
comes of acute seizures and epilepsy in children in Kenya,
aiming to inform future priorities for research, training, and
clinical service provision. We focus speciﬁcally on Kenya as
the country of practice (PS, JH, MK, SMK, CRN) and
collaboration (JMW, JAH) of all the authors and the site of
the majority of epilepsy research for the East African com-
munity. Kenya is a lower MIC, whereas the other ﬁvecoun-
tries in the community (Burundi, Rwanda, South Sudan,
Tanzania, and Uganda) are classiﬁed as low-income. In addi-
tion to possible differences in health-care access and provi-
sion amongcountries related to income level, there will be
other country-speciﬁc contextual factors that may affect the
epilepsy burden in each country. We discuss factors pertinent
to Kenya in this review.
Methods
In order to understand the pathways to epilepsy diagnosis
and management of children in Kenya we sought to
answer these questions: What is the burden of childhood
epilepsy in Kenya?; What is known about the causes,
presenting clinical features, management, and outcomes
of these children?
A literature search was undertaken using the terms
“eilepsy” OR “seizure” as exploded subject headings
AND “Kenya”. No date or language restriction was used.
Medline, Embase, Global Health, and CAB abstract data-
bases and the World Health Organization Library database
were searched, generating a total of 908 articles.
Titles and abstracts of all articles were screened to remove
any duplicates or obviously irrelevant papers. Those published
more than 15 years prior to the search were excluded. A total
of 154 papers remained, for which the full article was accessed
and reviewed by two authors independently (JH and JAH).
Inclusion criteria were papers published 2004–2018, papers
presenting data speciﬁc to Kenya, and papers presenting
pediatric-speciﬁc data. Excluded were case reports, animal
and in vitro studies, studies speciﬁcally addressing seizures
in malaria rather than all-cause acute seizures, studies from
countries other than Kenya, and studies that did not present
speciﬁc pediatric data.
This review speciﬁcally focuses on pediatric epilepsy.
Of note, 57 papers regarding epilepsy in adults were
excluded during screening and a further nine excluded on
full-text review for lack of subanalysis of the pediatric
population.
Included papers were categorized according to the
major theme or themes that they addressed: epidemiology,
etiology, clinical features including diagnosis, manage-
ment, and outcomes. Information extracted from included
studies was location (region and health care–facility level),
study design, number of participants, and the main
ﬁndings.
Papers that followed the International League Against
Epilepsy deﬁnition of epilepsy as two unprovoked seizures
occurring at least 24 hours apart were considered. Papers
reporting both interictal and ictal electroencephalography
(EEG) ﬁndings among those with epilepsy were consid-
ered for this analysis, and also if they reported the fre-
quency of abnormalities, such as abnormal background,
focal changes, epileptiform discharges, and abnormal
response to activation procedures on EEG recordings.
Medical comorbidities were considered if the studies
explicitly described the methods of diagnosis, such as
detailed clinical examination, review of medical records,
or standardized neuropsychological assessments.
Scope of published literature on
childhood epilepsy
We identiﬁed a total of 35 papers that fulﬁlled inclusion
criteria (Figure 1). Of these, 33 were from one high-
output group from the Kenya Medical Research
Institute–Wellcome Trust research programme based in
the rural coastal county of Kiliﬁ, a malaria-endemic
area with an ethnic makeup of predominantly Bantu
peoples. Most studies were based either on screening
data from large population surveys or retrospective obser-
vational cohorts of children admitted to Kiliﬁ district
hospitals (Table 1). Epilepsy was the focus of 26 papers,
and acute seizures or convulsive status epilepticus the
focus of the remaining nine(Table 2). The most common
themes were epidemiology and etiology, followed by
clinical presentation, including comorbidities, manage-
ment, and outcomes (Table 3).
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Results
Epidemiology
A total of 17 papers addressed prevalence or incidence of
acute seizures or epilepsy (Table 2). Observed data ranges
are summarized in Table 3. Twelve of the studies were
cross-sectional surveys with up to 232,176 participants
that identiﬁed children with epilepsy using the Ten
Questions Questionnaire11 administered by ﬁeld workers.
A common theme in epidemiological studies of child-
hood epilepsy was the exclusion of children aged <6 years,
because febrile seizures are common in this age-group and
would confound estimates. In studies presenting subanalyses
by age-group, as expected, prevalence of epilepsy increased
with age, while incidence decreased with age and the highest
incidence was in the 0- to 5-year age-group.1,2
Published estimates of lifetime epilepsy prevalence in
Kiliﬁ ranged from 20.9 of 1,000 (2017, n=11,233, children
aged 6–9 years)12 to 41 of 1,000 (2008, n=10,218, children
aged 6–12 years).13 Prevalence of active convulsive epi-
lepsy was estimated in Kiliﬁ to be 2 of 1,000 children aged
0–5 years3 to 11.5 of 1,000 children aged 6–9 years.12
Estimates for incidence of active convulsive epilepsy in
Kiliﬁ ranged from 39.6 of 100,000/year (age 13–17 years)2
to 187 of 100,000/year (aged 6–12 years),11 while inci-
dence of acute seizures was estimated at 312 of 100,000/
year (<13 years)13 to 879 of 100,000/year (<5 years)14 and
incidence of neonatal seizure at 443–3,950 of 100,000 live
births.5,15
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Figure 1 PRISMA ﬂow diagram.
Table 1 Methodology
Number of papers
Population survey 12
Cohort (observational) 13
Case–control Four, plus two nested
Social science 5
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Etiology of epilepsy in Kenyan children
Sixteen papers addressed etiology, including seven cross-
sectional surveys exploring risk factors for epilepsy or
acute seizures and seven case–control studies focusing on
speciﬁc associations.
The commonest association with active convulsive epi-
lepsy was history of perinatal and/or neonatal complications,
with ORs 2.88–5.70.5,7,12 Personal and family history of
acute symptomatic febrile or afebrile seizures were also
common predisposing factors for epilepsy.7,13 These ﬁndings
were also consistent with those of a multicountry study of
ﬁve sub-Saharan African sites, including Kiliﬁ.1
Parasitic infections were also associated with epilepsy.
Falciparum malaria infection is not only a risk for acute
seizures but also for later development of epilepsy,15,16 with
increased prevalence of epilepsy in children previously
admitted with cerebral malaria (9.2%, OR, 4.4, 95% CI 1.4–
13.7) or malaria complicated with seizures (11.5%, OR, 6.1,
95% CI 2.0–18.3) in malaria-endemic Kiliﬁ.17 Other parasitic
infections are implicated in the pathogenesis of epilepsy, and
studies fromAfrican sites outside of Kenya that included adult
patients have identiﬁed associations including Taenia solium,
which causes neurocysticercosis,10 toxoplasmosis,5
onchorcerciasis,18 tuberculosis19 and T. canis.1 Other identi-
ﬁed uninfectious predisposing conditions for childhood epi-
lepsy include traumatic head injuries, sickle-cell disease,
stroke, and acute encephalopathy.8–10,16
Risk factors for acute symptomatic seizures among
children admitted to hospital were similar to those for
active epilepsy identiﬁed in community surveys.
Infections were common. Studies from Kiliﬁ identiﬁed
falciparum malaria as the primary diagnosis in up to
65.4% children with acute symptomatic seizures,5,6,15–21
while respiratory tract infections were the primary diag-
nosis in up to 27.8%5,6,22 and any infection identiﬁed in
80% of children with acute symptomatic seizures.5,6,15
Five percent of children admitted to hospital with acute
symptomatic seizures hadepilepsy,14 a signiﬁcant
Table 2 Scope of published papers
Number of papers
2004–2009 2010–2014 2015–2018 TOTAL
Total number of papers 14 11 10 35
Location
Kiliﬁ (coast, malaria, endemic) 13 10 10 33
Western Kenya (malaria, endemic) 0 1 0 1
Nairobi (capital city) 1 0 0 1
Primary focus
Active convulsive epilepsy 3 7 2 12
Any / lifetime epilepsy 7 2 5 14
Acute seizures 3 1 2 6
Convulsive status epilepticus 1 1 1 3
Epidemiology 5 5 7 17
Prevalence 3 4 5 12
Incidence 3 3 2 8
Etiology 3 7 6 16
Clinical features 4 2 7 13
Electroencephalograph ﬁndings 3 0 4 7
Comorbidities 2 1 2 5
Management 4 2 4 10
Drug management 0 2 4 6
Outcomes 2 6 4 10
Death 2 2 2 6
Sequelae 2 3 1 6
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association (HR 1.53, 95% CI 1.10–2.14). The high bur-
den of neonatal seizures was attributed to neonatal sepsis
in 51%–61% cases, speciﬁcally to meningitis in 15% and
to neonatal encephalopathy in 21%.14,15,20
Two Kiliﬁ-based case–control studies examined speci-
ﬁc genetic or biochemical risk factors for acute seizures in
children admitted to hospital. There was no difference
between the number of cases and controls with the HP2-
2 haptoglobin genotype or with α-globin gene deletion,15
whilea meta-analysis of case–control studies identiﬁed a
small increased risk of afebrile seizures in children with
iron deﬁciency. We did not identify any other published
genetic studies of people with epilepsy in Kenya.
Epilepsy characterization and comorbidities
A total of 13 papers containing data on clinical features
were identiﬁed in this review, including seven cohort
studies describing neurophysiology and ﬁve describing
comorbidities.
Seizure semiology, electroencephalography, and imaging
In children with epilepsy, generalized tonic–clonic sei-
zures were reported in 33.6%–70.4% and focal-onset
seizures in 13.1%–78.6%.5,12,15,22 On EEG, any
abnormality was reported in 20%–39% children with
epilepsy5,12,14,23 and focal abnormalities in up to
61.6% of abnormal EEGs in 5- to 9-year-olds.23 In a
retrospective review of 6,639 pediatric EEGs performed
for suspected epilepsy and reviewed at Kenyatta
National Tertiary Referral Hospital, 3 Hz spike-wave
activity, a feature of childhood absence epilepsy, was
seen in 7.4% (163 of 2,216) of abnormal EEGs and
hypsarrhythmia, seen with infantile spasms, in 2.8%
(62 of 2,216) of abnormal EEGs.23 One Kiliﬁ study6
assessed children presenting with acute seizures and
found complex (focal, prolonged, or recurrent) seizures
in 84%, generalized seizures in 85%, and EEG abnorm-
alities in 27%. Another reported convulsive status epi-
lepticus in 35.4% children with acute seizures.13
Table 3 Summary of results by topic
Range of results (pediatric)
Prevalence
● Acute seizures*
● ACE
● Lifetime epilepsy
61/1,000 (age 1–6 years, Kariuki 2018)
2/1,000 (age 0–5 years, Ngugi 2013b)–11.5/1000 (age 6–9 years, Kind 2017)
20.9/1,000 (age 6–9 years, Kind 2017)–41/1,000 (age 6–12 years, Mung’ala-Odera 2008)
Incidence
● Acute seizures*
● CSE*
● Neonatal seizures (age ≤28 days)
● ACE
312/100,000/year (<13 years, Serem 2015)–879/100,000/year (age <5 years, Idro 2008)
268/100,000/year (age 1–11 months, Sadaragani 2008)
443/100,000 live births/year (Serem 2015)–3,950/100,000 live births (Mwaniki 2010)
39.64/100,000/year (age 13–17 years, Ibinda 2014)–187/100,000/year (age 6–12 years,Mung’ala-Odera 2008)
Clinical features
● Focal-onset seizures in ACE
● EEG abnormal in ACE
●Comorbid cognitive impairment in ACE
●Comorbid behavioural difﬁculties inACE
16% (6–9 years, Carter 2004)–78.6% (6–9 years, Kind 2017)
20% (6–12 years, Mung’ala-Odera 2008)–41.3% (5–9 years, Jowi 2008)
30.6% (6–9 years, Kariuki 2012)–31% (6–18 years, Munyoki 2010)
49% (6–9 years, Kariuki 2012)–54% (6–9 years, Kind 2017)
Management
● Taking anti-seizure medication 6.9% (0–18, Kariuki 2015)–28.6% (6–18 years, Munyoki 2010)
Outcomes
● Mortality in those with acute seizures
●Neuro-sequela following acute seizures
● Neuro-sequela following CSE
● Standardised mortality ratio in ACE
● DALYs in active epilepsy
3.1% (<13 years, Idro 2008)–6% (<13 years, Serem 2015)
1.3% (<13 years, Idro 2008)
30.9% (Prins 2014)
16.96 (6–12 years, Ibinda 2014)
617/100,000 years (13–17 years, Ibinda 2014)–900/100,000 years (0–4 years, Kariuki 2015)
Note: *Extrapolated from hospital admissions; may be underestimated.
Abbreviations: ACE, active convulsive epilepsy; CSE, convulsive status epilepticus; EEG, electroencephalography; DALYs, disability-adjusted life years.
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We identiﬁed one small study of neuroimaging (brain
computerized tomography) that included eleven children
with focal seizures with loss of awareness; however, no
abnormalities were found in this subgroup of children,
possibly due to the limited sensitivity of this modality
for detection of small lesions.24 There were no published
studies of more advanced neuroimaging, such as magnetic
resonance imaging, in this data set.
Comorbidities
A study done in rural Kenya by Kariuki et al7 showed that
children with epilepsy had a greater proportion of behavioral
and emotional problems (49%) thancontrols (26%).25–27
Children with active epilepsy had higher scores compared
to those with inactive epilepsy. Speciﬁc behavioral and emo-
tional problems were inability to maintain social relation-
ships and concentration. Similar ﬁndings were observed by
Kind et al,12 who found that 54% of those with lifetime
epilepsy had neurobehavioral comorbidities. These included
attention deﬁcit hyperactivity disorder, autism-spectrum dis-
order, and cognitive impairments (OR 14.55, 36.83, and
14.55, respectively). Other behavioral problems documented
in children with epilepsy included aggression, temper tan-
trums, and excessive crying.25–27
Epilepsy management
We identiﬁed ten papers in total. Six studies8,12,21,22,28,29
assessed whether children were on medical treatment for
epilepsy, although we only able to extract pediatric-speci-
ﬁc data from three of these.12,21,22 The other four were
qualitative observational studies of caregiver attitudes
towards epilepsy and the impact of these attitudes on
treatment-seeking behaviors.
Drug management of epilepsy
In Kiliﬁ-based studies, the maximum identiﬁed proportion of
children with active convulsive epilepsy on antiseizure med-
ication (ASM) detected in blood was 28.6%, of which two-
thirds oﬂevels were within the optimal therapeutic range,30
while self-reported antiepileptic-drug use was as low as 6.9%
in children (all age-groups) in a study by Kariuki et al21. No
studies addressed speciﬁc ASM regimes.
Nonbiomedical beliefs and practices inﬂuencing
access and care
Caregivers and parents of children with epilepsy in Kiliﬁ
categorized those with less frequent seizures as “healthy”,
requiring no urgent medical attention, while those with
frequent seizures were considered “sickly”, with treatment
believed to be futile.31 In some communities, epilepsy is
perceived to be contagious and/or associated with
witchcraft.32 Traditional healers in Kiliﬁ associated epi-
lepsy with natural spirits known as nyagu and ancestral or
evil spirits (majini).32 They described seizures occurring
when spirits descend upon a child, and interpreted ictal
movements as the child trying to break free from the hold
of the spirits, whilevocalization prior to a seizure was inter-
preted as surprise at the sudden appearance of spirits.32
In Kiliﬁ, people with epilepsy frequently seek treat-
ment from traditional healers who may offer explanations
and treatment that are concordant with perceptions held by
the community.31 Traditional healers were described as
having a more accessible communication style, allowed
more time for consultation than biomedical practitioners,
and were found to be popular, reliable, and trustworthy.
Flexible payment systems, with options to pay in install-
ments, barter trade, or pay at a later date, also contributed
to the popularity of traditional healers.32,33
A single study examined the effect of biomedical
health education on beliefs about epilepsy and on treat-
ment adherence. The authors found minimal change in
medication adherence following a single educational
encounter; however, the intervention group had signiﬁ-
cantly fewer beliefs regarding traditional causes of epi-
lepsy, cultural treatment, and negative stereotypes than the
nonintervention group.5
Outcomes of epilepsy
Ten papers presented data on outcomes, of which ﬁve were
district hospital–based cohorts of children with acute sei-
zures, one was a hospital cohort of epilepsy patients, and
four were cross-sectional surveys of children with epi-
lepsy. All studies reported increased risk of death and
neurological sequelae in both children admitted with
acute seizures and children with epilepsy.
Ibinda et al2 modeled outcomes based on cross-sectional
survey epidemiological data from Kiliﬁ, and calculated that
the standardized mortality ratio for children with active con-
vulsive epilepsy ranged from 1.7 (95% uncertainty interval
1.6–1.7) in females aged 0–5 years to 16.95 (95% uncertainty
interval 16.4–17.9) in males aged 6–12 years. In their pro-
spective cross-sectional study Ngugi et al34 reported 33.3
deaths per 1,000 persons with active convulsive epilepsy
per year over the study period, six times higher than the
general population, while on pediatric sub-analysis, adjusted
mortality ratio was up to 1.53 (95% CI 0.67–3.54) in 13- to
18-year-olds and 96.1% of deaths in this age-group were
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directly attributed to their epilepsy. Children with epilepsy
also had a higher burden of disability-adjusted life years,
with estimates ranging from 617–900 of 100,000 years2,30
and an increased disability-adjusted life-year burden in those
with secondary epilepsy and in children not on ASM.2
Nonadherence to ASM and prolonged seizures were closely
associated with epilepsy mortality.35,36
Childhood epilepsy was associated with increased hos-
pital-admission rates. In a Kiliﬁ study, the incidence of
hospital admissions due to epilepsy was 45.6 per 100,000
person-years of observation.13 The commonest causes of
admission13,15 among children with epilepsy were convul-
sive status epilepticus (38%–41%), postictal coma, and
epilepsy-related injuries, and convulsive status epilepticus
was the commonest cause of in-hospital death (5.4%).15
Mortality in children admitted to hospital with acute sei-
zures in the malaria-endemic area of Kiliﬁ was reported in
3.1%–6%,5,15 with higher mortality found in those with medi-
cally refractory (8%)5 or neonatal seizures (10%).5 Adverse
neurological outcomes were reported in 1.3% of children
admitted with seizures,22 while 13% of neonates with seizures
had neurological abnormalities at discharge.22 In a 3- to 4-year
postadmission (to Kiliﬁ District Hospital) follow-up study of
patients with convulsive status epilepticus, 30.9% of cases vs
3.9% of matched controls (OR 11, 95% CI 5.3–22.8) had
neurological impairment.35 Identiﬁed risk factors for death in
children with acute seizures included coma, acidosis, hypogly-
cemia, bacteremia, bacterial meningitis, and focal-onset sei-
zures. Adjusted risks for neurological sequelae were coma,
status epilepticus, hypoxic ischemic encephalopathy, severe
wasting, hypoglycemia, and age <12 months.15,37
Discussion
Epilepsy is a public health concern and a growing focus of
research in Kenya. The emerging impact of incommunicable
diseases in LMICs makes research in neurological disorders,
especially epilepsy, an urgent priority. The existing population
studies on childhood epilepsy in Kenya are restricted to the
malaria-endemic district of Kiliﬁ, which limits effective under-
standing of epidemiology of the condition on a national scale.
Burden, risk factors, and causes of epilepsy
in children
Since acute-seizure data are inferred from hospital admissions,
they may underestimate true incidence in the community. The
burden of neonatal seizures was noted to be particularly high,
and this is likely a signiﬁcant underestimate, given that more
than half of neonatal seizures are subclinical and can be
detected only with ictal neurophysiology recording, and a
signiﬁcant number of births in that region still occur at
home. These population data may also underestimate the
true burden of childhood epilepsy in this country for various
reasons, including stigma and differences in documentation of
the condition arisingfrom differences in case deﬁnition.18,36
We did not identify any particular temporal trends in
the prevalence or incidence of epilepsy; however, Kariuki
et al30 observed a decrease in incidence of acute sympto-
matic seizures from 2002 to 2008, with 93.1% of this
change attributed to treatment of malaria, reﬂecting similar
ﬁndings from other studies.10,15
Kenya has both malaria-endemic and nonendemic
regions. However, we did not identify any epidemiological
data on epilepsy or seizure from nonendemic areas, where the
frequency of these conditions may be signiﬁcantly different.
This limited understanding of the epidemiology of childhood
seizure disorders across Kenya limits the ability to inform a
national agenda for epilepsy prevention and management.
Further multisite research is needed to better understand the
causes of childhood seizure disorders nationwide.
Features and comorbidities of childhood
epilepsy
The ethnic makeup of the Kiliﬁ population is predomi-
nantly Bantu subgroups, with the highest proportion being
Mijikenda, while representation of other prominent
Kenyan ethnicities, such as the Nilotic peoples, is low.
Therefore, with regard to genetic etiologies of epilepsy,
Kiliﬁ may not be representative of the wider population of
Kenya. There have been no published studies from Kenya
investigating the known genetic associations with seizures
or epilepsy that are reported in high-income settings.
As with incidence and prevalence estimates, we found
no published studies of seizure-disorder etiology from
malaria-nonendemic regions of Kenya. We anticipate that
the burden of perinatal complications, the commonest risk
factor for childhood epilepsy, to be high nationwide,
although this may vary, depending on the quality of avail-
able maternal and newborn health–care services.
The high burden of focal-onset seizures and focal
EEG abnormalities implies that a signiﬁcant number of
Kenyan children with seizures/epilepsy may have lesional
causes due to potentially preventable or curable condi-
tions, including infections and acquired brain injuries. At
present, videotelemetry is not available in Kenya, and
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thus ictal EEG recordings are not collected, which limits
delineation of focus and semiology. International epilepsy
guidance recommends neuroimaging for children with
focal-onset seizures. In our experience, adherence to this
guidance is variable, due to a combination of cost, access
to imaging facilities, and physician knowledge.
Treatment gap and management of
epilepsy in children
Data on childhood-epilepsy management in Kenya is
limited. Culturally driven health-seeking behaviors
contribute to a low rate of epilepsy diagnosis, as well
as poor access to treatment, and are thought to be key
contributors to the treatment gap.28–34 The treatment
gap, which describes the percentage of people with
active epilepsy with no access to adequate medical
treatment, is very large in Kenya.28–33 Children have
the highest incidence of epilepsy, and thus are dispro-
portionately affected, adversely impacting their educa-
tion, psychosocial development, and quality of life in a
critical period of development.29 Barriers to children
with epilepsy receiving regular seizure prophylaxis
include underdiagnosis, lack of access to appropriate
health-care facilities and medications, and local non-
biomedical belief systems and practices.33 These
beliefs contribute to social exclusion of people with
epilepsy by their communities. Fear of stigma is likely
to discourage those affected from seeking medical
attention.
Access to health care for children with
epilepsy
Kenyan children with epilepsy face barriers to access in
every aspect of clinical care. Lack of recognition of epilepsy
by people with epilepsy, their caregivers, and health-care
professionals, due in part to low awareness of the condition,
have contributed to lack of treatment-seeking and conse-
quently signiﬁcant underdiagnosis and underreporting of
epilepsy. Whereas no peer-reviewed studies have addressed
access to health care, it has been observed that facilities for
the diagnosis and management of childhood epilepsy in
Kenya are severely limited. There is a marked paucity of
relevant specialist skilled human resources in Kenya: only
ﬁve Kenyan pediatricians have received any neurology train-
ing, and there are no pediatric-subspecialty neurosurgeons,
epilepsy neurosurgeons, pediatric epileptologists or pediatric
neuroradiologists.
The majority of people with epilepsy in Kenya present
to dispensaries and other peripheral facilities, and are
initially reviewed by clinical ofﬁces, nurses. or medical
ofﬁcers at presentation. Depending on the individual
health-care worker’s clinical acumen and training, the
diagnosis of epilepsy may be missed, especially with
such presentations as childhood-absence epilepsy.
Training for ﬁrst-line health workers caring for children
with epilepsy is limited in part due to the lack of specia-
lists with the experience and qualiﬁcations to provide such
training. Lack of training contributes to poor communica-
tion between health care workers and patients with epi-
lepsy on the causes, diagnosis, management, and prognosis
of the disorder, further widening the treatment gap.38
Health facilities in many areas lack specialized hospital
equipment crucial for investigation of epilepsy, such as
magnetic resonance–imaging scanners and EEG equip-
ment. Public health-care facilities for children with epi-
lepsy in Kenya are particularly limited, and national
investment in such infrastructure and efforts to integrate
epilepsy care into the existing primary health-care system
is inadequate.39,40
Better-staffed and equipped hospitals are found in the
larger cities, forcing the majority of those affected to travel
long distances, which is costly in terms of both transport
and time away from work, in addition to the direct costs of
health care.34,35 Kenyans employed within the formal sec-
tor or who opt to make independent contributions are able
to access the National Health Insurance Fund, which sub-
sidizes care; however, <20% of Kenyans have such cover.
The vast majority of low-income families in Kenya must
make direct out-of-pocket payments for specialist care.
Many families are simply unable to afford such payments,
so children go untreated and are at increased risk of dis-
ability and death from epilepsy-related complications.41
An additional barrier to adequate care for children with
epilepsy is access to ASMs, especially within in primary
health-care facilities.39,42,43 Phenobarbital, a medication
with known efﬁcacy and low cost, is listed as a controlled
drug in LMICs,40 preventing easy access. Poor quality
control of ASMs has also resulted in inﬁltration of fake
drugs into the informal lower-cost markets that are
accessed by many patients: phenobarbital and phenytoin
are among the drugs popular in the illegal market in
Kenya.44
The multifaceted barriers to health-care access are
compounded by low prioritization of epilepsy within
national and global health agendas. Incommunicable
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diseases, including epilepsy, have not been given impor-
tance as a major public health concern. Moreover, since
children with epilepsy are frequently treated within the
mental-health sector, it is important to note that national
mental-health policies are outdated and there exists no
legislation advocating for the rights of people with men-
tal-health issues in Kenya.38 Currently, there are no local
peer-reviewed studies that address access to health care.
Recent innovations in delivery of
epilepsy care in Kenya
The Ministry of Health, in collaboration with the National
Epilepsy Coordination Committee, has in recent years
produced guidelines for diagnosis and treatment algo-
rithms, including types of medication, dosage, and fre-
quency of administration and referral guidelines,
indicated for each level of care from primary health-care
facilities to referral hospitals.45 However, awareness and
implementation of these guidelines is yet to be reviewed.
Such organizations as the Kenya Association for the
Welfare of People with Epilepsy and Foundation for People
with Epilepsy have assisted in creating awareness, initiation of
community epilepsy-treatment programs, and facilitating sup-
port groups for people with epilepsy. Community-focused
collaborative epilepsy projects involving the government,
researchers, the National Epilepsy Coordination Committee,
and international medical teams have also been initiated in the
country. These provide a viable approach in caseﬁnding, using
key informants to facilitate diagnosis.44–48 On December 1,
2018, the Government of Kenya launched a World Health
Organization-supported pilot program of universal health cov-
erage in four counties.47 The stated aims of the program
include comprehensive, free-at-point-of-access coverage of
all medical conditions, including chronic care.
Task-sharing is increasingly recognized as a mechan-
ism to reduce the burden on medical specialists and over-
come workforce shortages while improving the care of
people with chronic conditions. A study in the Kibera
informal settlement in Nairobi found that nurses were
able to adhere effectively to management protocols for
incommunicable diseases, including epilepsy.49
Finally, ﬁve pediatric epilepsy training (PET1) courses
have been hosted since 2017 in Kenya, in conjunction with
the British Paediatric Neurology Association. This course
aims to improve health care–worker knowledge, diagnosis,
and management of childhood epilepsy. In 2018, a full
East African faculty was trained to lead PET training in
the region. Evaluation of the impact of this initiative
aandplans for further PET trainings are under way.
Future prospects
Early diagnosis and treatment of childhood epilepsy
improves prognosis and mitigates against the impact of
various of comorbidities.50,51 The most urgent priorities in
the management of childhood epilepsy in Kenya are effec-
tive strategies to prevent acquired brain injuries that may
result in epilepsy, early recognition and effective diagnosis
of the condition, and effective and accessible management,
including treatment with ASM.
In order to improve primary preventive strategies to
reduce the national burden of epilepsy, we need better to
understand the epidemiology and etiology of the condition
nationwide, including in noncoastal and non-malaria–
endemic areas and across different ethnic groups. One
potential platform for such work would be the current
clinical information network of 14 district hospital sites
across Kenya, excluding Kiliﬁ and representing both
malaria-endemic and nonendemic areas.52 Primary preven-
tive interventions, eg, improved perinatal care or reduced
burden of infectious diseases, are out of the scope of this
review.
An important step in improving seizure control will be
ensuring an adequate and quality-controlled supply of all of
the ASMs on the World Health Organization essential med-
icines list.53 There have been no randomized clinical trials
of epilepsy treatments in Kenya, and these are needed to
establish the most effective treatments for this population.
Epilepsy surgery has been performed successfully in a
number of Kenyan patients, but there areno pediatric data,
nor is a dedicated epilepsy surgery service providing com-
prehensive presurgical evaluation.54 Epilepsy surgery may
be of particular beneﬁt to the large cohort of Kenyan
children with focal-onset seizures, as has been demon-
strated in other regions.54
Finally, novel drug treatments, including cannabidiol
and new technologies such as γ-knife surgery, are emer-
ging in clinical practice in HICs, but are inaccessible to the
majority of Kenyan patients.55 Partnerships between
LMICs and HICs may help in capacity-building through
skill training and potentially introduction of new evidence-
based treatments at affordable cost.56,57
The majority of the data included in this review were
obtained from one highly productive group in the country.
There is a need to promote and expand on this quality of
research. The sustainability of such research is essential
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and must be supported to grow. More researchers are
needed to provide data to direct clinical needs and advise
practice. Therefore, actions to improve prevention, diag-
nosis, and management of childhood epilepsy in Kenya
will require national leadership and strategic long-term
partnerships among government, health-care providers,
and research institutions
The ﬁndings presented in this paper may be helpful in
other LMIC settings, but it is important to consider the
unique characteristics of each country, which can be contex-
tually different from Kenya’s. For example, the increased
burden of epilepsy stigma, nonadherence to treatment, and
medical and psychiatric comorbidities is likely to apply in
many other LMIC settings as well, but the underlying risk
factors may vary. Risk factors are dependent on ecological
and geographical distribution of countries, as well as their
economic levels and sociocultural integration. In Kenya,
malaria would be an important risk factor for epilepsy, but
in other countries onchocerciasis and neurocysticercosis
would be the priority target infections for programs aimed
at reducing the burden of epilepsy. Sociocultural determi-
nants of epilepsy treatment may be different across countries,
and inﬂuence the development of educational interventions
to improve diagnosis and management of epilepsy. In Kiliﬁ,
working with traditional healers through an education inter-
vention helps reduce the treatment gap, but it is unknown if a
similar approach would work in other settings. There may be
differences in organization and resourcing of the health-care
systems, meaning the suggested public health interventions
for epilepsy will need different strategies of implementation
and evaluation. Kenya has a devolved system of governance,
which has strengthened the primary health-care systems,
making it ideal for introducing and evaluating public health
interventions.
Conclusion
Kenya faces a high burden of epilepsy, particularly in
children, but nationwide the epidemiology of the condition
is poorly understood, particularly in non-malaria–endemic
areas. Cultural beliefs, stigma, and lack of access to treat-
ment and skilled human resources are causes of delayed
diagnosis and management of epilepsy. Potentially preven-
table etiologies, including adverse perinatal events, brain
injuries, and infections, including malaria, as well as
familial genetics are common risk factors and causes of
epilepsy in the country. Clinical ﬁndings suggest a high
prevalence of focal lesional epilepsy that may be due to
preventable causes. Premature mortality, neurological
sequelae, behavioral problems, frequent hospitalization,
and injuries are common sequelae for children with epi-
lepsy in Kenya, all of which point to extremely poor out-
comes. Adherence to ASM reduces the number of seizures
and improves overall quality of life, yet access to diagnos-
tics and medications is highly variable and the treatment
gap in Kenya remains unacceptably high.
There is urgent need for better public awareness of
epilepsy, improved epidemiological understanding of the
condition within Kenya, access to affordable quality health
care for all those affected, and improved facilities for the
diagnosis and treatment of epilepsy. A national strategy is
needed to inform further research and multisector
approaches to improve outcomes for children living with
epilepsy.
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